If you would like to present, start by submitting a proposal.
You will need the following: presentation type, short/long descriptions, keywords, focus, themes, and biographical information.
After we receive your presentation proposal, it moves to the evaluation step. We welcome the submission of proposals at anytime of the year.All proposals will be reviewed between 24- 48 hr of submission by the Organizing Committee.
Once your proposal is accepted, you must register before our Program Development team can schedule your presentation.
Full continuum of drug discovery and development, including genomics and proteomics reporting on research, applications, technologies, and strategies to accelerate the pace and productivity of drug research and development. Pharmacotherapy, Clinical research, Translational medicine, translational and preclinical models, Case studies across therapeutic and disease areas
Pharmacovigilance in Drug Regulation, Clinical Trials, Premarketing clinical safety, Postmarketing drug safety, Risk management strategies, Signal detection and data mining, Detection of drug interactions, International harmonization of drug regulatory requirements, Risk and crisis management, Herbal and Traditional Medicines, Vaccines and biological medicines
Recent therapeutic application and development approaches of formulation systems to improve the drug delivery potential, Drug Delivery Carrier, Trasdermal Drug Delivery Systems, Nanoparticles, Mucoadhesive Drug Delivery System, Novel Drug Delivery System, Market Opportunities, Biomaterials in Drug Delivery, Administration routes, Future Opportunities and Challenges, , Drug Therapy
Drug therapy monitoring, drug therapy problems, Anti-Cancer Drug Discovery & Therapy, Cancer Targeted Drug Delivery, Cardiovascular Drug Discovery & Therapy, CNS Drug Discovery & Therapy, Diabetes And Obesity Drug Discovery & Therapy, Pulmonary Drug Discovery & Therapy,Women’s Health Drug Discovery & Therapy.
Central and peripheral neurotransmission, Neurotoxicology, Nerve growth factors, Neural cytoskeletal elements, Brain repair, Cellular and molecular mechanisms of addiction, Developmental and neurodegenerative disorders, Neuro-immune interactions, Neurotoxicology, Nutrient transport in the brain, Synaptic development and plasticity
Data-Driven Health and Personalization, Role of Artificial Intelligence in pharma, Global digital transformation, Measuring success in digital ROI and evaluating digital analytics, Aligning innovation with business objectives, Multichannel engagement, Marketing in a Multichannel World, Customer's Digital Habits, Channel Preferences, New Levels of Targeting, Investment Allocation, Mobilizing for Mobile Engagement, Metrics to a True Learning Plan
Clinical Pharmacology including cardiac pharmacology and cardiovascular disease, pulmonary disease, neurodegenerative disorders, pharmacological oncology, Parkinson’s disease, circadian rhythm disorders, Molecular and Cellular Pharmacology including drug-receptor interactions, drug-enzyme interactions, pharmacology of antibiotics and immune responses, regulation of gene expression, Pharmacogenetics, Safety Pharmacology, Toxicology, Pharmacognosy, Environmental Pharmacology
Recent research and advancement, Clinical Trials, Patient centric approaches to clinical trials, Innovations in Pre-clinical Research, Medical Imaging , Participation In a Clinical Trial, Trials covering more than one phase, Multi-arm multi-stage (MAMS) trials, Pharmacodynamics, Screening, Ethical aspects, Patient safety, International Regulatory affairs, Quality assurance, Biosimilars, Biologic products, Liscencing and approvals, International Guidelines Impacting Regulatory Affairs, Regulatory and post-marketing issues.
Pharmaceutical Formulations Market, Licensing, Pharma Pricing & Market Access, Global Generic Trends & Global Pharma Market, E-pharma marketing, Post-market surveillance, Generic Drug Market and Contract Manufacturing Manufacturing and Health Economics, Predictive Analytics, Pre-clinical Discovery, Commercial Models, Customer Lifetime Valuation, Patient-Centricity, Segmentation/Localisation of Pharma, Big Data, Architecture, Informatics, Statistical Approaches for Improving Performance and Compliance
Drug-gene testing, Parmacogenomics and Personalized medicine, Challenges, Drug labelling, Current limitations, Genetics and Drug Sensitivity, Pharmacogenomics testing costs and coverage, Predicting drug-drug interactions, Polypharmacy, Association- and expression-based methods, Cheminformatics and pathway-based methods , Applications of pharmacogenomics into a clinical setting, Genotyping and Phenotyping
Recent advances in the field of Pharmaceutical Biotechnology, Basic techniques and tools used in Recombinant DNA Technology, Vectors, Cloning Strategies and Host systems, Applications of genetic engineering in the production of some recombinant therapeutic proteins, vaccines, Recombinant blood products and therapeutic enzymes, Nucleic-acid- and cell-based therapeutics.
Nanoparticle synthesis, Nanocarriers, Applications of Pharmaceutical Nanotools, Future prospects of Pharmaceutical Nanotechnology, Nanomedicine and Drug Delivery, Toxicological assessment of nanomaterials as drugs. Characterization, clinical testing and biological evaluation of nanomaterials.
Herbal drug analysis methods, Plant micromorphology, Role of medicinal plants, Bioactive pharmaceuticals, Complementary and alternative, Integrative medicine, Biologically Based Therapies, Energy medicine, Traditional medicine, holistic medicine, Traditional ethnic systems, herbal remedies, Prevalence of use, Interactions with conventional pharmaceuticals, Traditional Chinese Medicine, Effectiveness and Safety
Nutraceuticals in Disease Prevention and Therapy, Personalized nutrition and medicine, Probiotics and Prebiotics, Nutraceuticals for Weight Management, Dietary Supplements & Functional foods, Nutraceuticals Market- Trends, Probiotics and prebiotics, Skincare Supplements and Cosmetics,Nutraceuticals Markets-Growth trends,
Analytical Techniques, Mass Spectrometry Method Development and Validation, HPLC Method Development and Validation, Spectroscopic Techniques, Mass Spectrometry in Bioanalysis, Advances in Sample Preparation for Bioanalytical Techniques, Qualitative Analytical Techniques, Qualitative Analysis
Rare diseases, Immunological Rare diseases, Treatment and Advanced Therapies options for Rare Diseases, Rare Hereditary diseases, Orphan Drugs Policy, Gene therapy development, Development Trends and Strategies on Orphan Drugs, Challenges in Rare Diseases, Clinical Research and Drug Approvals for Rare Diseases, Cell and Gene therapies, Genetic testing, Gene editing
Role of cosmetics, Biological effects of cosmetics, Regulation frame, How cosmetics differentiate from drugs, Product Testing, Microbiological Safety and Cosmetics, SkinCare and HairCare, Packaging, Safety and efficacy, Anti-ageing and tissue repair processes, Opportunities and challenges for biotech product development, Cosmeceuticals and the market , Food-cosmetic interface and interaction, Animal Testing, Plastic microbeads, Endocrine disruptors, Counterfeit products